Abstract

Evidence of harm reduction interventions’ morbidity and mortality benefits is abundant and of high quality, so there are good reasons for regional and national groups to advocate for more widespread distribution of legally regulated “drug paraphernalia,” including needles, syringes, and fentanyl test strips. But lack of consistency among states’ laws means that patients’ interstate travel can subject them to being charged with possession of illegal items. This commentary on a case offers guidance to clinicians looking to help patients understand legal risks of interstate travel with supplies that are prescribed or recommended to reduce harms of their drug use and explores the ethical responsibilities of physicians in jurisdictions that legally prohibit these harm reduction interventions.

Original languageEnglish (US)
Pages (from-to)527-533
Number of pages7
JournalAMA journal of ethics
Volume26
Issue number7
DOIs
StatePublished - Jul 2024

ASJC Scopus subject areas

  • Issues, ethics and legal aspects
  • Health(social science)
  • Health Policy

Fingerprint

Dive into the research topics of 'When Are “Paraphernalia” Critical Medical Supplies?'. Together they form a unique fingerprint.

Cite this